Product Description

🔹 Product Overview
Guficandin 70 mg Injection is used in the management of certain serious fungal infections. Caspofungin works by inhibiting the formation of β-(1,3)-D-glucan, an important component of the fungal cell wall, thereby weakening susceptible fungal cells.

Brand: Guficandin 70 mg Injection
Active ingredient: Caspofungin 70 mg
Drug class: Echinocandin antifungal
Therapeutic category: Antifungal
Dosage form: Powder for solution for intravenous infusion
Strength: 70 mg per vial
Route: Intravenous infusion
Prescription status: Prescription medicine
Manufacturer/marketer: Criti Care LLP is listed for the product.

🔹 Key Uses
Caspofungin is used for certain serious fungal infections, including:
Invasive candidiasis
Candidemia
Invasive aspergillosis in appropriate patients
Certain suspected or confirmed invasive fungal infections where an echinocandin is clinically appropriate
The exact indication depends on the patient's infection, clinical condition and treatment history.

🔹 Composition
Active ingredient: Caspofungin 70 mg
The 70 mg vial contains caspofungin as the acetate salt. Official product information identifies the dosage form as a powder that is reconstituted and diluted before intravenous administration.

🔹 How It Works
Caspofungin inhibits the synthesis of β-(1,3)-D-glucan, an essential structural component of the fungal cell wall.
By interfering with cell-wall formation, caspofungin makes susceptible fungal cells structurally unstable, which inhibits fungal growth and contributes to their destruction.

🔹 Key Benefits
Used for treatment of certain serious invasive fungal infections
Contains Caspofungin 70 mg
Belongs to the echinocandin class of antifungals
Targets an essential component of the fungal cell wall
Suitable for hospital-based intravenous antifungal therapy when prescribed
May be used when appropriate based on the identified or suspected fungal infection

🔹 Dosage and Administration
Guficandin 70 mg should only be administered by a healthcare professional. It is not an oral tablet and should not be self-administered.
The appropriate caspofungin regimen depends on the indication, clinical circumstances, age, weight and liver function. A 70 mg dose may be used as a loading dose in certain adult treatment regimens, followed by a lower maintenance dose when clinically appropriate; the 70 mg vial should therefore not be interpreted as the routine daily dose for every patient.
The powder must be properly reconstituted and diluted before intravenous infusion according to the approved product instructions.

🔹 Possible Side Effects
Possible adverse effects of caspofungin may include:
Fever
Chills
Headache
Nausea
Diarrhoea
Rash
Injection/infusion-site reactions
Changes in liver enzymes
Changes in blood potassium levels
Serious allergic or infusion-related reactions can occur. Patients should immediately inform the healthcare team if they develop breathing difficulty, facial or throat swelling, severe rash or other signs of a serious reaction.

🔹 Precautions and Warnings
Use only under specialist medical supervision.
Tell your doctor if you have liver disease or abnormal liver-function tests.
Inform your doctor about all medicines you are taking because caspofungin can interact with certain drugs.
Liver function may be monitored during treatment.
Tell your healthcare professional if you develop a rash, fever, chills or other unusual symptoms during infusion.
Use during pregnancy only when specifically recommended by a doctor.
Do not attempt to prepare or administer the injection yourself.